Penumbra Inc
No enriched coverage for $PEN in the last 7 days.
No SEC Form 4 filings for $PEN in the last 30 days.
Vanguard Capital Management has reported a beneficial ownership of 1,990,629 shares in Penumbra Inc. (NYSE: PEN), which represents a 5.07% stake. This information is disclosed in a Schedule 13G SEC filing, indicating Vanguard's passive investment intentions. The filing details Vanguard's sole dispositive power over all 1.99 million shares and sole voting power over 296,141 shares, signed by Ashley Grim.
Penumbra has announced its 2026 annual stockholder meeting for June 18, 2026, where shareholders will vote on director elections, auditor ratification, and executive compensation. A separate special meeting will address the proposed $14.5 billion acquisition by Boston Scientific Corporation, valuing Penumbra shares at $374 each, with consideration split between cash and Boston Scientific stock. The proxy statement details the financial terms of the merger and outlines the company's executive compensation philosophy, which emphasizes base salary and long-term equity awards.
Penumbra Inc. (PEN) filed an ARS form with the SEC on April 29, 2026. This filing is available as a PDF document and has a low impact and neutral sentiment. The article also provides an overview of Penumbra, including its market capitalization, recent news, and other SEC filings.
